Enhancing the Divergent Activities of Betulinic Acid via Neoglycosylation-Reference-Cited by-同舟云学术

Enhancing the Divergent Activities of Betulinic Acid via Neoglycosylation

Published:2008-12-22 Issue:2 Volume:11 Page:461-464
ISSN:1523-7060
Container-title:Organic Letters
language:en
Short-container-title:Org. Lett.

Author:

Goff Randal D.¹,Thorson Jon S.¹

Affiliation:

1. University of Wisconsin National Cooperative Drug Discovery Group, Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin−Madison, 777 Highland Ave., Madison, Wisconsin 53705

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ol8025704

Reference45 articles.

1. Sweet antibiotics – the role of glycosidic residues in antibiotic and antitumor activity and their randomization

2. Natures Carbohydrate Chemists The Enzymatic Glycosylation of Bioactive Bacterial Metabolites

3. The role of carbohydrates in biologically active natural products

4. Colchicine Glycorandomization Influences Cytotoxicity and Mechanism of Action

5. In vitro antineoplastic activity of C7-substituted mitomycin C analogues MC-77 and MC-62 against human breast-cancer cell lines

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Borane–Trimethylamine Complex: A Versatile Reagent in Organic Synthesis;Molecules;2024-04-27

2. Novel MeON-glycosides of ursolic acid: Synthesis, antitumor evaluation, and mechanism studies;Fitoterapia;2023-09

3. Design, synthesis, and biological evaluation of 3,3′-diindolylmethane N-linked glycoconjugate as a leishmanial topoisomerase IB inhibitor with reduced cytotoxicity;RSC Medicinal Chemistry;2023

4. Design and synthesis of NAD(P)H: Quinone oxidoreductase (NQO1)-activated prodrugs of 23-hydroxybetulinic acid with enhanced antitumor properties;European Journal of Medicinal Chemistry;2022-10

5. Synthesis, biological evaluation and mechanism studies of C-3 substituted nitrogenous heterocyclic 23-Hydroxybetulinic acid derivatives as anticancer agents;Fitoterapia;2022-07